ArticleDiscover oncology2025

Retraction Note: Identifying therapeutic target for prostate cancer: exploring Diosmetin as a CYP inhibitor.

Mohammad Habibur Rahman Molla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.